These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 26253002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.
    Dobard C, Sharma S, Martin A, Pau CP, Holder A, Kuklenyik Z, Lipscomb J, Hanson DL, Smith J, Novembre FJ, García-Lerma JG, Heneine W.
    J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766
    [Abstract] [Full Text] [Related]

  • 3. Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.
    Makarova N, Henning T, Taylor A, Dinh C, Lipscomb J, Aubert R, Hanson D, Phillips C, Papp J, Mitchell J, McNicholl J, Garcia-Lerma GJ, Heneine W, Kersh E, Dobard C.
    AIDS; 2017 Mar 27; 31(6):745-752. PubMed ID: 28060011
    [Abstract] [Full Text] [Related]

  • 4. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.
    Parikh UM, Dobard C, Sharma S, Cong ME, Jia H, Martin A, Pau CP, Hanson DL, Guenthner P, Smith J, Kersh E, Garcia-Lerma JG, Novembre FJ, Otten R, Folks T, Heneine W.
    J Virol; 2009 Oct 27; 83(20):10358-65. PubMed ID: 19656878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.
    Tsegaye TS, Butler K, Luo W, Radzio J, Srinivasan P, Sharma S, Aubert RD, Hanson DL, Dobard C, Garcia-Lerma JG, Heneine W, McNicholl JM, Kersh EN.
    J Acquir Immune Defic Syndr; 2015 Aug 01; 69(4):385-94. PubMed ID: 25886925
    [Abstract] [Full Text] [Related]

  • 7. Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.
    García-Lerma JG, Aung W, Cong ME, Zheng Q, Youngpairoj AS, Mitchell J, Holder A, Martin A, Kuklenyik S, Luo W, Lin CY, Hanson DL, Kersh E, Pau CP, Ray AS, Rooney JF, Lee WA, Heneine W.
    J Virol; 2011 Jul 01; 85(13):6610-7. PubMed ID: 21525346
    [Abstract] [Full Text] [Related]

  • 8. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
    Dobard CW, Taylor A, Sharma S, Anderson PL, Bushman LR, Chuong D, Pau CP, Hanson D, Wang L, Garcia-Lerma JG, McGowan I, Rohan L, Heneine W.
    J Infect Dis; 2015 Dec 15; 212(12):1988-95. PubMed ID: 26071566
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques.
    Dobard CW, Makarova N, West-Deadwyler R, Taylor A, Dinh C, Martin A, Lipscomb J, Mitchell J, Khalil G, Garcia-Lerma G, Heneine W.
    J Infect Dis; 2018 Sep 08; 218(8):1284-1290. PubMed ID: 29788316
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.
    Nuttall J, Kashuba A, Wang R, White N, Allen P, Roberts J, Romano J.
    Antimicrob Agents Chemother; 2012 Jan 08; 56(1):103-9. PubMed ID: 21986823
    [Abstract] [Full Text] [Related]

  • 12. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.
    Moss JA, Malone AM, Smith TJ, Butkyavichene I, Cortez C, Gilman J, Kennedy S, Kopin E, Nguyen C, Sinha P, Hendry RM, Guenthner P, Holder A, Martin A, McNicholl J, Mitchell J, Pau CP, Srinivasan P, Smith JM, Baum MM.
    Antimicrob Agents Chemother; 2012 Nov 08; 56(11):5952-60. PubMed ID: 22964245
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
    Massud I, Cong ME, Ruone S, Holder A, Dinh C, Nishiura K, Khalil G, Pan Y, Lipscomb J, Johnson R, Deyounks F, Rooney JF, Babusis D, Park Y, McCallister S, Callebaut C, Heneine W, García-Lerma JG.
    J Infect Dis; 2019 Oct 22; 220(11):1826-1833. PubMed ID: 31362305
    [Abstract] [Full Text] [Related]

  • 14. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
    Stolte-Leeb N, Loddo R, Antimisiaris S, Schultheiss T, Sauermann U, Franz M, Mourtas S, Parsy C, Storer R, La Colla P, Stahl-Hennig C.
    AIDS Res Hum Retroviruses; 2011 Sep 22; 27(9):933-43. PubMed ID: 21332419
    [Abstract] [Full Text] [Related]

  • 15. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, Berry N, Ham C, Heeney J, Rezk N, Kashuba A, Anton P, McGowan I, Shattock R.
    PLoS Med; 2008 Aug 05; 5(8):e157; discussion e157. PubMed ID: 18684007
    [Abstract] [Full Text] [Related]

  • 16. Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques.
    Makarova N, Singletary T, Peet MM, Mitchell J, Bachman S, Holder A, Dinh C, Lipscomb J, Agrahari V, Mendoza M, Pan Y, Heneine W, Clark MR, García-Lerma JG, Doncel GF, Smith JM.
    J Infect Dis; 2024 Jun 14; 229(6):1791-1795. PubMed ID: 38134382
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.
    Cong ME, Mitchell J, Sweeney E, Bachman S, Hanson DL, Heneine W, García-Lerma JG.
    J Infect Dis; 2013 Aug 01; 208(3):463-7. PubMed ID: 23633402
    [Abstract] [Full Text] [Related]

  • 18. Multipurpose Prevention Approaches with Antiretroviral-Based Formulations.
    Jean-Pierre N, Barnable P, Kizima L, Rodríguez A, Seidor S, Cooney ML, Clark MR, Doncel GF, Robbiani M, Zydowsky TM, Teleshova N, Fernández-Romero JA.
    Antimicrob Agents Chemother; 2016 Feb 01; 60(2):1141-4. PubMed ID: 26596943
    [Abstract] [Full Text] [Related]

  • 19. Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques.
    Cong ME, Youngpairoj AS, Aung W, Sharma S, Mitchell J, Dobard C, Heneine W, Garcia-Lerma JG.
    Virology; 2011 Apr 10; 412(2):435-40. PubMed ID: 21334708
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    Justman JE, Nair GL, Hendrix CW, Piper JM, Marzinke MA, Dai JY, Pan Z, Galaska B, Levy L, Schwartz JL, Balar B, Kunjara Na Ayudhya RP, Mushamiri I, McGowan I, Dezzutti CS, MTN-014 Study Team.
    J Acquir Immune Defic Syndr; 2018 Jun 01; 78(2):175-182. PubMed ID: 29767639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.